Consumer telehealth · Male fertility diagnostics
Path Fertility
Path Fertility offers SpermQT, an epigenetic sperm quality test from Inherent Biosciences that goes beyond standard semen analysis metrics. It is not a mail-in sperm freezing and storage kit.
Strong fit
- Couples and clinicians who need more than a standard semen analysis and are looking at SpermQT epigenetic sperm quality testing
- Fertility clinics adding advanced male testing to workups after normal count and motility results
- Buyers comparing next-step male fertility tests beyond mail-in count kits
Weak fit
- Men who only need a basic at-home count and motility kit with optional freezing
- Patients seeking sperm storage as the primary product
- Buyers who need a full telehealth hormone and testosterone clinic rather than a test
Bottom line
Path Fertility is worth considering for men whose standard semen analysis looks normal but whose fertility remains uncertain. Its SpermQT test looks at epigenetic markers. Men who want at-home collection, lab analysis, and sperm freezing should look at Fellow or Legacy.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Path Fertility is the male fertility testing brand of Inherent Biosciences, co-founded by CEO Andy Olson and chief science officer Kristin Brogaard.
Its SpermQT test looks at epigenetic markers linked to the ability to fertilize, rather than only count, motility, and shape. The company is young and has a small team.
It is an advanced test, not a mail-in collection and storage kit like Fellow or Legacy. That limits who should buy it first.
Fellow or Legacy suit at-home collection, CLIA lab analysis, and freezing. Posterity Health suits broader male fertility telehealth and hormones.
Among the male fertility services we review, Path scores near Sppare.me at the lower end.
The test fills a real gap in diagnosis. But its consumer offer, storage, and shipping are thinner than those of full-service kit brands like Fellow or Legacy.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Fellow | 8.3 | 8.0 |
| Legacy | 8.2 | 8.3 |
| Posterity Health | 7.4 | 7.3 |
| CryoChoice | 7.2 | 6.5 |
| Path Fertility | 6.6 | 6.4 |
| Sppare.me | 6.6 | 7.3 |
Pricing
| Item | Detail |
|---|---|
| Model | A SpermQT epigenetic sperm quality test ordered by a physician, with a posted cash price when you order. Prices through clinics may differ. |
| What usually drives cost | Cash or benefits coverage, ordering through a clinic or directly, and any added tests. |
| What to ask before you buy | The cash price for SpermQT and whether your clinic or benefits cover it. |
| Published pricing | Path Fertility lists SpermQT at roughly $385 cash. Confirm the current price on pathfertility.com. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Path Fertility to function | |
| A clinician who will order the test | SpermQT is not a test to order on a whim. |
| Earlier semen analysis results on hand | Advanced testing without a basic result first is confusing. |
| Following the sample collection instructions | Bad samples waste the test. |
| A fertility clinic follow-up visit booked | Results without a plan stall decisions. |
| Checking cash price against benefits coverage | Surprise bills kill trust. |
| What will maximize your value | |
| Use it after a standard semen analysis when results are unexplained | Starting here can lead to too much testing. |
| Bring results to a reproductive urologist or fertility specialist | The test is an input, not a treatment. |
| Avoid treating it as sperm storage | Storage is a different product. |
| Deal-breakers | |
| You only want a mail-in count kit with freezing | |
| You need a testosterone clinic | |
| You will not use a lab test ordered by a clinician | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Order and kit | 1-2 weeks |
| 2 | Lab processing | Depends on the lab |
| 3 | Clinic consult | 1-3 weeks |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.